CV Sciences (CVSI) Capital Expenditures Growth (3y) (2016 - 2021)
CV Sciences (CVSI) Capital Expenditures Growth (3y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 6.52% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 232.22% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 34.64% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 147.53% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 28.56% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -15.83% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -61.38% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 89.86% |
| 10 | CV Sciences | - | - | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -36.70% |
| Dec 31, 2020 | -35.73% |
| Jun 30, 2020 | 59.48% |
| Sep 30, 2019 | 184.68% |
| Dec 31, 2018 | -152.30% |
| Sep 30, 2018 | 5,104.83% |
| Jun 30, 2018 | 50.40% |
| Mar 31, 2018 | 22.70% |
| Dec 31, 2017 | 64.01% |
| Jun 30, 2017 | -68.47% |
| Sep 30, 2016 | -54.62% |